文献速递胃肠外科肝胆胰外科

Siewert II型和III型食管胃结合部腺癌下胃周淋巴结转移的危险因素及临床意义:一项回顾性队列研究

Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study.
PubMed 文献 · Surg Endosc · 2024-05-31

该回顾性队列纳入302例接受全胃切除术的Siewert II型和III型食管胃结合部腺癌患者,分析下胃周淋巴结(包括第4d、5、6和12a站)转移的危险因素。独立危险因素为肿瘤远端距食管胃结合部>4.0 cm、术前CEA(+)、pT4期和HER-2(+);下胃周淋巴结转移是全胃切除术后总生存的独立危险因素。下胃周淋巴结转移率8.6%,效率指数2.31%。

要点

  • 肿瘤远端距EGJ>4.0 cm、术前CEA(+)、pT4期和HER-2(+)是下胃周淋巴结转移的独立危险因素。
  • 下胃周淋巴结转移是全胃切除术后总生存的独立危险因素。
  • 下胃周淋巴结转移率8.6%,效率指数2.31%。

核心结论

  • 下胃周淋巴结转移是Siewert II型和III型食管胃结合部腺癌患者预后的不良因素。
  • 对于术前CEA(+)、pT4期、HER-2(+)以及肿瘤远端距食管胃结合部>4.0 cm的患者,优先临床推荐全胃切除联合下胃周淋巴结清扫。

研究设计与样本

  • 回顾性队列研究,纳入302例连续接受全胃切除术的Siewert II型和III型食管胃结合部腺癌患者。
  • 采用逻辑回归模型进行下胃周淋巴结转移危险因素的单因素和多因素分析。
  • 采用Kaplan-Meier曲线进行生存分析,采用对数秩检验进行组间比较。
  • 依据日本胃癌学会指南,进一步评估各淋巴结站的转移及效率指数。

主要发现

  • 下胃周淋巴结转移的独立危险因素为肿瘤远端距食管胃结合部>4.0 cm、术前CEA(+)、pT4期和HER-2(+)。
  • 下胃周淋巴结转移是全胃切除术后总生存的独立危险因素。
  • 下胃周淋巴结转移率为8.6%,效率指数为2.31%。
  • 在肿瘤远端距食管胃结合部>4.0 cm、pT4期、术前CEA(+)和HER-2(+)分层下,下胃周淋巴结转移率>10%的效率指数分别为3.55%、2.09%、2.51%和3.64%。

关键数值与推荐

  • 下胃周淋巴结包括第4d、5、6和12a站淋巴结。
  • 下胃周淋巴结转移率8.6%,效率指数2.31%。
  • 肿瘤远端距食管胃结合部>4.0 cm分层下,下胃周淋巴结转移率>10%时效率指数为3.55%。
  • pT4期分层下,下胃周淋巴结转移率>10%时效率指数为2.09%。
  • 术前CEA(+)分层下,下胃周淋巴结转移率>10%时效率指数为2.51%。

临床怎么用

  • 对于术前CEA(+)、pT4期、HER-2(+)以及肿瘤远端距食管胃结合部>4.0 cm的患者,优先临床推荐全胃切除联合下胃周淋巴结清扫。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No consensus has been concluded with regarding to the scope of lymph node (LN) dissection for Siewert type II and III adenocarcinoma of the esophagogastric junction (AEG). This study aimed to explore risk factors for lower perigastric LN (LPLN) metastases (including no. 4d, 5, 6, and 12a LN stations) and analyze the indications for LPLN dissection. METHODS: In total, 302 consecutive patients with Siewert type II and III AEG who underwent total gastrectomy (TG) were enrolled. The logistic regression model was used to perform uni- and multivariate analyses of risk factors for LPLN metastases. Kaplan-Meier curves were used for survival analysis, and log-rank tests were used for group comparisons. Basing on the guidelines of Japanese Gastric Cancer Association, the LN metastases (LNM) as well as the efficiency index (EI) of each LN station was further evaluated. RESULTS: The independent risk factors for LPLN metastases in patients with Siewert type II and III AEG were distance from the esophagogastric junction (EGJ) to the distal end of the tumor (> 4.0 cm), preoperative carcinoembryonic antigen (CEA) ( +), pT4 stage, and HER-2 ( +). LPLN metastases was an independent risk factor for overall survival following TG. The LNM and EI of LPLN were 8.6% and 2.31%, respectively. The LNM of LPLN > 10% under the stratification of the distance from the EGJ to the distal end of the tumor (> 4.0 cm), pT4, preoperative CEA ( +), and HER-2 ( +) exhibited EI values of 3.55%, 2.09%, 2.51%, and 3.64%, respectively. CONCLUSIONS: LPLN metastases was a malignant factor for the prognosis of patients with Siewert type II and III AEG. For patients with preoperative CEA ( +), pT4 stage, HER-2 ( +), and the distance from the EGJ to the distal end of the tumor (> 4.0 cm), TG with LPLN dissection is prioritized for clinical recommendation.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Qi X, Liu M, Xu K, et al. Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study. Surg Endosc. 2024. PMID: 38822144. doi:10.1007/s00464-024-10875-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。